Beaton B, Sasson SC, Rankin K, Raedemaeker J, et al. Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses. Am J Hematol 2023;98:131-139.
PMID: 35607995